Dr. Brandon DeKosky is an Assistant Professor in the Department of Chemical Engineering at MIT and a Core Member of the Ragon Institute of MGH, Harvard, and MIT. Research efforts at the DeKosky lab have developed a suite of high-throughput single-cell platforms for large-scale analyses of adaptive immunity. These efforts are advancing new approaches in biologic drug discovery, and for the cataloguing the vast genetic and functional diversity of adaptive immune cells in multiple disease settings. Key application areas include infectious disease interventions, especially malaria and HIV-1 prevention, and the development of personalized cancer therapeutics.
Dr. DeKosky is the recipient of The Antibody Society’s 2022 James S. Huston Antibody Science Talent Award. He has also been awarded other honors for his research program. His Ph.D. research was supported by a Hertz Foundation Fellowship and an NSF Graduate Fellowship. In 2016, DeKosky was awarded a K99 Pathway to Independence Award and an NIH Early Independence Award and began a joint faculty appointment at the University of Kansas Departments of Chemical Engineering and Pharmaceutical Chemistry. He has also received the Department of Defense Career Development Award, the Biomedical Engineering Society Rising Star Award, and the AIChE Young Faculty Futures award.